Skip to main content
    C

    Cytosorbents Crp (CTSO)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $4.85
    -0.02 (-0.41%)

    Market Cap: $15.35M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Cytosorbents Crp (CTSO) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Cytosorbents Crp (CTSO) to earn -$4.40 per share in the fiscal year ending Dec 31, 2026, on revenue of $38.88M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down. For the quarter ending Dec 31, 2026, the EPS consensus is -$0.71.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$4.40-$4.40 to -$4.402$38.88M$38.15M to $39.61M2

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.71-$0.78 to -$0.635$10.67M$9.72M to $11.55M4

    Estimate Revisions

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202602

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$3.70.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$4.40-$4.40-$3.70-$3.70-$3.70N/A

    Frequently Asked Questions About CTSO

    What is the CTSO stock forecast?

    Consensus analyst estimates put Cytosorbents Crp's EPS at -$4.40 for the fiscal year ending Dec 31, 2026, on revenue of $38.88M.

    What EPS do analysts expect from CTSO next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$4.40, with estimates from -$4.40 to -$4.40 from 2 analysts.

    What revenue do analysts expect from Cytosorbents Crp next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $38.88M, with estimates from $38.15M to $39.61M.

    How many analysts cover CTSO?

    2 analysts estimate EPS for Cytosorbents Crp for the fiscal year ending Dec 31, 2026.